CHAPEL HILL, N.C.--(BUSINESS WIRE)--Jul. 18, 2012--
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company
committed to transforming medicine that transforms lives, announced
today that it plans to release second quarter 2012 results on August 1,
2012, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m. (ET)
with a discussion by POZEN management of the earnings and business
results. The webcast can be accessed on POZEN’s website at www.pozen.com
and will be archived and available for replay. The second quarter 2012
earnings release will be accessible in the Media section of POZEN’s
POZEN Inc. is a progressive pharmaceutical company that is transforming
how the healthcare industry addresses unmet medical needs. By utilizing
a unique in-source model and focusing on integrated therapies, POZEN has
successfully developed and obtained FDA approval of two self-invented
products in two years. Funded by these milestone/royalty streams, POZEN
is now creating a portfolio of cost-effective, evidence based integrated
aspirin therapies designed to enable the full power of aspirin by
reducing its GI damage.
POZEN is currently seeking strategic partners to help maximize the
opportunity for its portfolio assets.
The Company's common stock is traded under the symbol “POZN” on The
NASDAQ Global Market. For more detailed company information, including
copies of this and other press releases, please visit www.pozen.com.
Source: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
Manager, Investor Relations & Public